Simbulan-Rosenthal, C. M., Dakshanamurthy, S., Gaur, A., Chen, Y., Fang, H., Abdussamad, M., . . . Rosenthal, D. S. (2017). The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRAS(Q61K) melanoma. Oncotarget.
استشهاد بنمط شيكاغوSimbulan-Rosenthal, Cynthia M., et al. "The Repurposed Anthelmintic Mebendazole in Combination With Trametinib Suppresses Refractory NRAS(Q61K) Melanoma." Oncotarget 2017.
MLA استشهادSimbulan-Rosenthal, Cynthia M., et al. "The Repurposed Anthelmintic Mebendazole in Combination With Trametinib Suppresses Refractory NRAS(Q61K) Melanoma." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.